Literature DB >> 18982438

Comparison of single and double vein approaches for His bundle ablation and pacemaker placement for symptomatic rapid atrial fibrillation.

Ravishankar Kalaga1, Rosemary Kahr, Magdy Migeed, Ravi Yarlagadda, Christopher A Clyne.   

Abstract

BACKGROUND: His Bundle ablation (HBA) with permanent pacemaker (PPM) implantation is an effective strategy for controlling heart rate in symptomatic patients with rapid atrial fibrillation (AF), resistant to pharmacologic therapy. The standard double vein (DV) approach involves mapping and HBA from a femoral approach to achieve complete heart block (CHB), while single chamber (SC), dual chamber (DC), or biventricular (BiV) PPM is then placed via a subclavian approach.
METHODS: We compared 7 patients with drug-resistant rapid AF who underwent the standard DV approach to 8 patients who underwent a single vein (SV) approach, in which HBA and PPM implantation were performed through the subclavian vein. The two groups were compared for acute success in creating CHB, total procedure and fluoroscopy times and patient discomfort. Results are expressed as mean +/- standard error (SEM).
RESULTS: The procedure times for the SV versus DV were 70.4 +/- 11.4 v 100.0 +/- 19.2 min, and the fluoroscopy times, 13.9 +/- 3.1 (SV) v 13.0 +/- 2.9 (DV). All patients were discharged in stable condition with CHB and SC, DC pacemaker or BiV/Implantable Cardioverter Defibrillator (ICD). CHB with symptomatic improvement was maintained in all patients over a mean follow-up period of 22.6 months (SV), and 9.6 months (DV).
CONCLUSION: The SV approach for HBA combined with PPM implantation was at least as effective and may be more efficient than the classic DV approach, and should be considered as an alternative to DV technique to reduce procedural time and patient discomfort.

Entities:  

Mesh:

Year:  2008        PMID: 18982438     DOI: 10.1007/s10840-008-9319-x

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  15 in total

Review 1.  Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography.

Authors:  Robert L McNamara; Leonardo J Tamariz; Jodi B Segal; Eric B Bass
Journal:  Ann Intern Med       Date:  2003-12-16       Impact factor: 25.391

Review 2.  Atrioventricular node modification and ablation for ventricular rate control in atrial fibrillation.

Authors:  Gregory K Feld
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

3.  Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy.

Authors:  M Grogan; H C Smith; B J Gersh; D L Wood
Journal:  Am J Cardiol       Date:  1992-06-15       Impact factor: 2.778

4.  Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study).

Authors:  Rahul N Doshi; Emile G Daoud; Christopher Fellows; Kyong Turk; Aurelio Duran; Mohamed H Hamdan; Luis A Pires
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

Review 5.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.

Authors:  William H Maisel; Lynne Warner Stevenson
Journal:  Am J Cardiol       Date:  2003-03-20       Impact factor: 2.778

6.  Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation.

Authors:  S H Lee; S A Chen; C T Tai; C E Chiang; Z C Wen; J J Cheng; Y A Ding; M S Chang
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

7.  Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2003-07-02       Impact factor: 24.094

8.  The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.

Authors:  G N Kay; K A Ellenbogen; M Giudici; M M Redfield; L S Jenkins; M Mianulli; B Wilkoff
Journal:  J Interv Card Electrophysiol       Date:  1998-06       Impact factor: 1.900

9.  The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT).

Authors:  Rukshen Weerasooriya; Michael Davis; Anne Powell; Tamas Szili-Torok; Chetan Shah; David Whalley; Logan Kanagaratnam; William Heddle; James Leitch; Ann Perks; Louise Ferguson; Max Bulsara
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.